Form 4: HCA Healthcare CEO Samuel Hazen Reports Changes in Beneficial Ownership

CEO Samuel Hazen reports a transaction involving HCA Healthcare common stock, including acquisitions and disposals through various trusts.

Summary

• Samuel Hazen, CEO of HCA Healthcare, filed a Form 4 detailing changes in his beneficial ownership of the company's common stock.
• On May 13, 2025, there were transactions involving the disposal of 90,076 shares of common stock from a 2022 GRAT at a price of $0.
• On the same date, 90,076 shares of common stock were acquired through a 2023 Trust at a price of $0.
• Following these transactions, Hazen directly owns 145,518 shares of common stock.
• He also indirectly owns shares through various trusts, including 813,320 shares via LP, 14,979 shares via HD Trust, 16,731 shares via 2023 GST Trust, and 250,000 shares via 2024 GRAT.
• The filing also covers derivative securities, but no specific transactions are detailed in this section.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their ownership, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the CEO's ownership stake in the company.

Key Dates

Keywords

HCA Healthcare, Samuel Hazen, Beneficial Ownership, Form 4, Common Stock, Transactions, Trusts, CEO